Search Orphan Drug Designations and Approvals
-
Generic Name: | Clenbuterol |
---|---|
Date Designated: | 01/09/2017 |
Orphan Designation: | Treatment of Pompe disease (glycogen storage disease type II) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Dwight D. Koeberl, MD, PhD Duke University Medical Center Pediatrics Dept., Div. of Genetics Durham, North Carolina 27710 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-